How many insider declarations has Thomas Dolca filed?

Thomas Dolca has filed 3 public insider declarations with SEC (Form 4).

What is Thomas Dolca's role?

Thomas Dolca's reported role is not specified by the regulator across the filings.

Which companies does Thomas Dolca report trades for?

Thomas Dolca reports trades for Chinook Therapeutics, INC..

What is Thomas Dolca's declared buy vs sell volume?

Across the available history, declared buys total 207k€ and disposals 0.

← Executives ★ Sign in to follow

TD

Thomas Dolca

·SEC (Form 4)

Chinook Therapeutics, INC.

0

申报总数

0

公司

€206,820

▲ 买入（1 笔）

—

▼ 卖出（0 笔）

内部人交易记录

其他

已披露买入

1

已披露卖出

0

尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。

信号历史

无可用的信号评分。

Discover the detailed record of transactions filed by Thomas Dolca. Officer active across 1 company, notably Chinook Therapeutics, INC.. In total, 3 filings have been published. Split: 1 buy · 0 sell. Total volume traded: €207k. Activity tracked since 2 September 2022. The latest transaction was filed on 2 September 2022 (Acquisition). Regulator: SEC (Form 4). The full history is free.

Companies and markets linked to Thomas Dolca

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Chinook Therapeutics, INC. (US)

申报3 总计

●

Thomas Dolca

Director高管2023年8月11日Chinook Therapeutics, INC.

0SEC ↗

13,300 股Common StockSEC:0001209191-23-045430:0

◇

Thomas Dolca

Director高管2023年5月26日Chinook Therapeutics, INC.

0SEC ↗

3,300 股Common StockSEC:0001209191-23-033186:0

▲

Thomas Dolca

Director高管2022年9月2日Chinook Therapeutics, INC.

US$205,83423SEC ↗

9,700 股@ US$21.22100.0% 占其流量Common StockSEC:0001209191-22-048759:0

标准退出：2022年12月1日 (T+90)

3 条申报中的 3 条

InsidersTradesSigma

← Executives ★ Sign in to follow

TD

Thomas Dolca

·SEC (Form 4)

Chinook Therapeutics, INC.

0

申报总数

0

公司

€206,820

▲ 买入（1 笔）

—

▼ 卖出（0 笔）

内部人交易记录

其他

已披露买入

1

已披露卖出

0

尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。

信号历史

无可用的信号评分。

Discover the detailed record of transactions filed by Thomas Dolca. Officer active across 1 company, notably Chinook Therapeutics, INC.. In total, 3 filings have been published. Split: 1 buy · 0 sell. Total volume traded: €207k. Activity tracked since 2 September 2022. The latest transaction was filed on 2 September 2022 (Acquisition). Regulator: SEC (Form 4). The full history is free.